Cargando…
Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women
BACKGROUND: Methamphetamine (MA) use during pregnancy is associated with many pregnancy complications, including preterm birth, small for gestational age, preeclampsia, and abruption. Hawaii has lead the nation in MA use for many years, yet prior to 2007, did not have a comprehensive plan to care fo...
Autores principales: | Wright, Tricia E, Schuetter, Renee, Fombonne, Eric, Stephenson, Jessica, Haning, William F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292917/ https://www.ncbi.nlm.nih.gov/pubmed/22260315 http://dx.doi.org/10.1186/1477-7517-9-5 |
Ejemplares similares
-
Prenatal harmful substances: Thai pregnant women’s experiences
por: Tantanokit, Jatuporn, et al.
Publicado: (2023) -
Meeting people where they are: implementing hospital-based substance use harm reduction
por: Perera, Rachel, et al.
Publicado: (2022) -
Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework
por: Wolfson, Lindsay, et al.
Publicado: (2021) -
Reduction in Substance-Related Composite Harm Scores Through Street Soccer
por: Bates, Alan T, et al.
Publicado: (2023) -
Prevention, early intervention, and harm reduction of substance use in adolescents
por: Jiloha, R. C.
Publicado: (2017)